Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.

The Lancet. Microbe

Massanella M, Ignacio RAB, Lama JR, Pagliuzza A, Dasgupta S, Alfaro R, Rios J, Ganoza C, Pinto-Santini D, Gilada T, Duerr A, Chomont N.
PMID: 34841369
Lancet Microbe. 2021 May;2(5):e198-e209. doi: 10.1016/s2666-5247(21)00010-0. Epub 2021 Mar 23.

BACKGROUND: Early antiretroviral therapy (ART) initiation (ie, within 3 months of infection) limits establishment of the HIV reservoir. However, the effect of early ART initiation on the long-term dynamics of the pool of infected cells remains unclear.METHODS: In this...

Cite
Massanella M, Ignacio RAB, Lama JR, et al. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study. Lancet Microbe. 2021;2(5):e198-e209doi: 10.1016/s2666-5247(21)00010-0.
Massanella, M., Ignacio, R. A. B., Lama, J. R., Pagliuzza, A., Dasgupta, S., Alfaro, R., Rios, J., Ganoza, C., Pinto-Santini, D., Gilada, T., Duerr, A., & Chomont, N. (2021). Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study. The Lancet. Microbe, 2(5), e198-e209. https://doi.org/10.1016/s2666-5247(21)00010-0
Massanella, Marta, et al. "Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study." The Lancet. Microbe vol. 2,5 (2021): e198-e209. doi: https://doi.org/10.1016/s2666-5247(21)00010-0
Massanella M, Ignacio RAB, Lama JR, Pagliuzza A, Dasgupta S, Alfaro R, Rios J, Ganoza C, Pinto-Santini D, Gilada T, Duerr A, Chomont N. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study. Lancet Microbe. 2021 May;2(5):e198-e209. doi: 10.1016/s2666-5247(21)00010-0. Epub 2021 Mar 23. PMID: 34841369; PMCID: PMC8622834.
Copy Download .nbib Format: NLM
Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.

medRxiv : the preprint server for health sciences

Ogimi C, Qu P, Boeckh M, Bender Ignacio RA, Zangeneh SZ.
PMID: 33106815
medRxiv. 2020 Oct 20; doi: 10.1101/2020.10.17.20214510.

We investigated whether countries with higher coverage of childhood live vaccines [BCG or measles-containing-vaccine (MCV)] have reduced risk of COVID-19 related mortality, accounting for known systems differences between countries. In this ecological study of 140 countries using publicly available...

Cite
Ogimi C, Qu P, Boeckh M, et al. Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis. medRxiv. 2020;doi: 10.1101/2020.10.17.20214510.
Ogimi, C., Qu, P., Boeckh, M., Bender Ignacio, R. A., & Zangeneh, S. Z. (2020). Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.10.17.20214510
Ogimi, Chikara, et al. "Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.10.17.20214510
Ogimi C, Qu P, Boeckh M, Bender Ignacio RA, Zangeneh SZ. Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis. medRxiv. 2020 Oct 20; doi: 10.1101/2020.10.17.20214510. PMID: 33106815; PMCID: PMC7587835.
Copy Download .nbib Format: NLM
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses.

mBio

White JM, Schiffer JT, Bender Ignacio RA, Xu S, Kainov D, Ianevski A, Aittokallio T, Frieman M, Olinger GG, Polyak SJ.
PMID: 34933447
mBio. 2021 Dec 21;12(6):e0334721. doi: 10.1128/mbio.03347-21. Epub 2021 Dec 21.

The world was unprepared for coronavirus disease 2019 (COVID-19) and remains ill-equipped for future pandemics. While unprecedented strides have been made developing vaccines and treatments for COVID-19, there remains a need for highly effective and widely available regimens for...

Cite
White JM, Schiffer JT, Bender Ignacio RA, et al. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio. 2021;12(6):e0334721doi: 10.1128/mbio.03347-21.
White, J. M., Schiffer, J. T., Bender Ignacio, R. A., Xu, S., Kainov, D., Ianevski, A., Aittokallio, T., Frieman, M., Olinger, G. G., & Polyak, S. J. (2021). Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio, 12(6), e0334721. https://doi.org/10.1128/mbio.03347-21
White, Judith M, et al. "Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses." mBio vol. 12,6 (2021): e0334721. doi: https://doi.org/10.1128/mbio.03347-21
White JM, Schiffer JT, Bender Ignacio RA, Xu S, Kainov D, Ianevski A, Aittokallio T, Frieman M, Olinger GG, Polyak SJ. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio. 2021 Dec 21;12(6):e0334721. doi: 10.1128/mbio.03347-21. Epub 2021 Dec 21. PMID: 34933447; PMCID: PMC8689562.
Copy Download .nbib Format: NLM
New skin lesions in a liver transplant recipient.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Blain M, Walter K, Sibulesky L, Ignacio RB.
PMID: 32194359
Am J Transplant. 2019 Oct;19(10):2955-2957. doi: 10.1111/ajt.15538.

No abstract available.

Cite
Blain M, Walter K, Sibulesky L, et al. New skin lesions in a liver transplant recipient. Am J Transplant. 2019;19(10):2955-2957doi: 10.1111/ajt.15538.
Blain, M., Walter, K., Sibulesky, L., & Ignacio, R. B. (2019). New skin lesions in a liver transplant recipient. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 19(10), 2955-2957. https://doi.org/10.1111/ajt.15538
Blain, Michela, et al. "New skin lesions in a liver transplant recipient." American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons vol. 19,10 (2019): 2955-2957. doi: https://doi.org/10.1111/ajt.15538
Blain M, Walter K, Sibulesky L, Ignacio RB. New skin lesions in a liver transplant recipient. Am J Transplant. 2019 Oct;19(10):2955-2957. doi: 10.1111/ajt.15538. PMID: 32194359; PMCID: PMC7010414.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries